Health Trials

Relapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

1

Review clinical trials related to Relapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

Participants needed: 108
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Ono Pharmaceutical Co., Ltd.Updated: Jun 3, 2025Locations: 14
Eligibility criteria

Angioimmunoblastic T-cell lymphoma(AITL) [+8]

Patients with severe complications. [+1]

Read more